BetterLife Pharma Inc. (BETRF)

BetterLife Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is February - January.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Jun 18, 2026	Jan 31, 2026	Jan 31, 2025	Jan 31, 2024	Jan 31, 2023	Jan 31, 2022
Market Capitalization	9	6	11	6	10	14
Market Cap Growth	-18.63%	-49.81%	77.29%	-35.21%	-26.56%	-75.00%
Enterprise Value	12	9	15	8	13	12
Last Close Price	0.06	0.04	0.09	0.06	0.11	0.16
PB Ratio	-1.91	-1.21	-2.26	-1.13	-1.77	-4.47
Debt / Equity Ratio	-0.14	-0.14	-0.18	-0.07	-0.02	-0.08
Net Debt / Equity Ratio	-0.14	-0.14	-0.18	-0.07	-0.02	-0.04
Net Debt / EBITDA Ratio	-	-	-	-0.16	-0.02	-0.01
Net Debt / FCF Ratio	-1.43	-1.43	-0.65	-0.21	-0.12	-0.01
Quick Ratio	0.00	0.00	0.00	0.01	0.00	0.12
Current Ratio	0.03	0.03	0.03	0.04	0.01	0.28
Return on Assets (ROA)	-508.19%	-508.19%	-1074.42%	-1004.42%	-936.16%	-493.00%
Return on Capital Employed (ROCE)	28.00%	28.00%	64.60%	45.70%	130.90%	334.40%
Earnings Yield	-12.06%	-19.10%	-21.15%	-33.29%	-67.53%	-70.08%
FCF Yield	-	-7.99%	-12.15%	-28.49%	-11.26%	-64.57%
Buyback Yield / Dilution	-17.77%	-17.77%	-13.34%	-26.25%	-14.70%	-179.24%

Data Source: S&P Global Market Intelligence Last updated: Jan 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 18, 2026

Data Sources Report a data error